Treatment of renal anemia using synthetic human erythropoietin
Blumberg, A.; Zehnder, C.
Therapeutische Umschau. Revue Therapeutique 45(12): 895-899
1988
ISSN/ISBN: 0040-5930 PMID: 3065970 Document Number: 323217
Document emailed within 1 workday
Related Documents
Dyjas, R.; Wiecek, A.; Kokot, F. 1996: Treatment of non-renal anemia with human recombinant erythropoietin (rHU-EPO Przeglad Lekarski 53(6): 486-490Kulzer, P.; Schaefer, R.M.; Krahn, R.; Schaefer, L.; Heidland, A. 1994: Effectiveness and safety of recombinant human erythropoietin (r-HuEPO) in the treatment of anemia of chronic renal failure in non dialysis patients. European Multicentre Study Group International Journal of Artificial Organs 17(4): 195-202
Wauters, J.P. 1990: Human recombinant erythropoietin: from clinical aspects to the physiopathology of anemia of renal insufficiency Revue Medicale de la Suisse Romande 110(11): 951-954
Lim, V.S. 1990: Does correction of anemia with recombinant human erythropoietin accelerate the progression of renal insufficiency? Seminars in Nephrology 10(2 Suppl. 1): 26-27
Hotta, T.; Ogawa, H.; Saito, A.; Ito, A. 1991: Iron balance following recombinant human erythropoietin therapy for anemia associated with chronic renal failure International Journal of Hematology 54(3): 195-200
Adamson, W.; Egrie, J.C.; Browne, J.K.; Downing, M.R.; Eschbach, W. 1988: The use of recombinant human erythropoietin (EPO) to correct the anemia of end-stage renal disease: a progress report Behring Institute Mitteilungen 1988(83): 188-192
Drüeke, T.; Zins, B.; Bererhi, L.; Casadevall, N.; Varet, B. 1989: Use of recombinant erythropoietin in the treatment of anemia of chronic renal insufficiency Presse Medicale 18(25): 1235-1237
Radermacher, J.; Koch, K.M. 1995: Treatment of renal anemia by erythropoietin substitution. The effects on the cardiovascular system Clinical Nephrology 44(Suppl): S56-S60
Hu, J.P.; Cheng, X.; Xu, X.F.; Yu, G.J.; Luo, F.; Zhang, G.S.; Yang, N.; Shen, P.; Yan, X.Y. 2016: Reactivity of patients with maintenance hemodialysis to erythropoietin in the treatment of renal anemia Journal of Biological Regulators and Homeostatic Agents 30(2): 535-540
Henry, D.H.; Beall, G.N.; Benson, C.A.; Carey, J.; Cone, L.A.; Eron, L.J.; Fiala, M.; Fischl, M.A.; Gabin, S.J.; Gottlieb, M.S. 1992: Recombinant human erythropoietin in the treatment of anemia associated with human immunodeficiency virus (HIV) infection and zidovudine therapy. Overview of four clinical trials Annals of Internal Medicine 117(9): 739-748
Zelichowski, G.; Lubas, A.; Sienkiewicz, M.; Janusz, E.; Wańkowicz, Z. 2008: Treatment of renal anemia with intravenous erythropoietin in patients in the program of continuous ambulatory peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 24(142): 312-315
Abels, R.I. 1992: Use of recombinant human erythropoietin in the treatment of anemia in patients who have cancer Seminars in Oncology 19(3 Suppl 8: 29-35
Valladares Ayerbes, M.J.; Valenzuela Claros, J.C.; Reina Zoilo, J.J.; Ruiz Borrego, M.; Moreno Nogueira, J.A. 1997: Human recombinant erythropoietin in the treatment of the anemia of multiple myeloma Anales de Medicina Interna 14(11): 593-594
Henry, D.H. 1993: Recombinant human erythropoietin for the treatment of anemia in patients with advanced cancer Seminars in Hematology 30(4 Suppl 6: 12-16
Boratyńska, M.; Szewczyk, Z.; Szepietowski, T.; Czyz, W.; Cybulski, K.; Bogucki, J.; Szczepański, J. 1990: Human recombinant erythropoietin in the treatment of anemia in patients on long-term hemodialysis Przeglad Lekarski 47(11): 741-745
Dallman, P.R. 1993: Anemia of prematurity: the prospects for avoiding blood transfusions by treatment with recombinant human erythropoietin Advances in Pediatrics 40: 385-403
Karwacki, M.; Ochocka, M.; Kubiak, W. 1994: Anemia in AIDS: the problem to avoid. Human recombinant erythropoietin in the treatment of HIV positive patients Przeglad Epidemiologiczny 48(4): 441-447
Sulková, S.; Laurincová, Z.; Kvasnicka, J. 1990: Does aluminum affect the effectiveness of human recombinant erythropoietin in the treatment of anemia in dialyzed patients? Casopis Lekaru Ceskych 129(4): 113-115
Lastiri, Jé.M.; Specterman, S.R.; Rendo, P.; Pallotta, Mía.G.; Varela, M.S.; Goldstein, Sía. 2002: Predictive response variables to recombinant human erythropoietin treatment in patients with anemia and cancer Medicina 62(1): 41-47
Queipo Zaragozá, J.é A.; Chicote Pérez, F.; Beltrán Meseguer, J.F.; Borrell Palanca, A.; Giner Marco, V.; Esteve Claramunt, J.ús.; Pastor Sempere, F. 2004: Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin Archivos Espanoles de Urologia 57(1): 35-40